Advik Laboratories has been restrained from progressing with key stages of the rights issue process, including regulatory filings, circulation of offer documents, acceptance of subscriptions, and allotment of shares.
Advik Laboratories' rights issue process has been stayed by the Delhi High Court. The company is restrained from key stages like regulatory filings, circulating offer documents, accepting subscriptions, and allotting shares. This development effectively halts the ongoing rights…
Market Samachar is a news aggregator. This article was originally published by mint - markets. Tap the button above to read the full story on their site.